~~<i id='FCB5148744'><strike id='FCB5148744'><tt id='FCB5148744'><pre id='FCB5148744'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：hotspot 2025-09-27 23:53:06 - browse：3

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Printout prescription drug information shouldn’t go digital

focus

hotspot

knowledge

hotspot

leisure time

AdobeTheCanadiansurgeonandurologistBalfourMountisconsideredthefatherofpalliativecareinNorthAmerica.H

WSS

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Obesity drugs seen as possible treatment for liver disease MASH

Prior authorization reform is both possible and imperative

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Obesity drugs seen as possible treatment for liver disease MASH

Maisha Meds is a PBM, but don't call it that

hotspot

explore

focus

The high cost of giving birth even with insurance

Dario to buy mental health app maker Twill in cash and stock deal

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare inequities exacerbate Puerto Rico’s health disparities

State Dept. review finds Biden bears some blame for Afghanistan failures

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Hollywood unions extend contract negotiations for actors

Immunocompromised patients offer clues on chronic Covid

hotspot

Dario to buy mental health app maker Twill in cash and stock deal

Pumping milk in bathrooms at health conferences is common

6 phony surgeries that take placebo to the extreme

Medicare inequities exacerbate Puerto Rico’s health disparities

Cardiologists urge adding sexual orientation, gender identity to health records

Head of FDA's diagnostics center, who led through Covid, retires

knowledge

hotspot

hotspot

leisure time